£107.98

Springer Nasopharyngeal Carcinoma: Keys for Translational Medicine and Biology: 778 (Advances in Experimental Medicine and Biology, 778)

Price data last checked 42 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£107.98 £107.38 £107.51 £107.64 £107.77 £107.90 £108.04 14 April 2026 26 April 2026 08 May 2026 20 May 2026 01 June 2026

Price Distribution

Price distribution over 49 days • 2 price levels

Days at Price
Current Price
15 days 34 days · current 0 9 17 26 34 £107 £108 Days at Price

Price Analysis

Most common price: £108 (34 days, 69.4%)

Price range: £107 - £108

Price levels: 2 different prices over 49 days

Description

This book takes a "translational medicine and biology" approach to Nasopharyngeal Carcinoma, developing knowledge from basic science towards diagnostic and therapeutic applications and reciprocally proposing new questions for basic scientists. About the Author Pierre Busson is a Senior Research Scientist at the CNRS (National Center for Scientific Research) and the Gustave Roussy Institute in Villejuif, close to Paris. He obtained his MD in 1983 and his PhD in Virology in 1990 from Paris University. Following a post-doctoral research fellowship at the Lineberger Cancer Research Center (Chapel Hill, North Carolina, USA), he was recruited by the CNRS in 1992 and established his own group in the Gustave Roussy Institute in 2001. His major research interests are cellular interactions in Epstein-Barr virus-associated nasopharyngeal carcinomas, with special emphasis on the role of tumor exosomes and other secreted nano-objects, in a perspective of translational research. Recently, his group has extended the same type of approach to ovarian carcinomas. He published about 75 articles in peer-reviewed scientific journals. Dr Pierre Busson has been member of the Board of the International Association for Epstein-Barr virus research from 2000 to 2004. He has been actively involved in the organization of bi-annual international meetings on nasopharyngeal carcinomas (2003, Villejuif; 2005, Toronto; 2007, Brisbane; 2009, Marrakech; 2011, Penang). He is a grant reviewer for several institutions in France, Europe and in Hong-Kong. He is academic editor for PLoS One and reviewer for about 20 journals.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
23 August 2016
Listed Since
09 September 2016

Barcode

No barcode data available

Similar Products You Might Like

Critical Issues in Head and Neck Oncology: Key Concepts from the Seventh THNO Meeting
77% match

Critical Issues in Head and Neck Oncology: Key Concepts from the Seventh THNO Meeting

Springer

£40.68 05 Jun 2026
Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer
76% match

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

Springer

£107.98 01 Jun 2026
Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer
76% match

Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer

Springer

£107.98 30 May 2026
Molecular Targets and Strategies in Cancer Prevention
76% match

Molecular Targets and Strategies in Cancer Prevention

Springer

£107.33 25 May 2026
Cancer of the Oral Cavity, Pharynx and Larynx: Evidence-Based Decision Making
76% match

Cancer of the Oral Cavity, Pharynx and Larynx: Evidence-Based Decision Making

Springer

£58.46 06 Jun 2026
HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)
76% match

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Springer

£73.10 30 May 2026
Translation and Its Regulation in Cancer Biology and Medicine
76% match

Translation and Its Regulation in Cancer Biology and Medicine

Springer

£93.56 05 Jun 2026
Translation and Its Regulation in Cancer Biology and Medicine
75% match

Translation and Its Regulation in Cancer Biology and Medicine

Springer

£115.43 03 Jun 2026
Papillomaviruses and Human Disease
75% match

Papillomaviruses and Human Disease

Springer

£79.78 04 Jul 2026
Infectious Agents and Cancer
75% match

Infectious Agents and Cancer

Springer

£73.44 28 May 2026
The Papillomaviruses
75% match

The Papillomaviruses

Springer

£107.98 06 Jun 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
75% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Papillomaviruses (Novartis Foundation Symposia)
75% match

Papillomaviruses (Novartis Foundation Symposia)

Wiley-Blackwell

£90.00 28 May 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
74% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£110.02 20 May 2026
Non-coding RNAs and Cancer
74% match

Non-coding RNAs and Cancer

Springer

£80.64 31 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
74% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 19 May 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
74% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Prostate Cancer: Shifting from Morphology to Biology
74% match

Prostate Cancer: Shifting from Morphology to Biology

Springer

£114.49 01 Jul 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
74% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£107.98 27 May 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
74% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£113.94 01 Jun 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
74% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.39 26 May 2026
Cancers in People with HIV and AIDS: Progress and Challenges
74% match

Cancers in People with HIV and AIDS: Progress and Challenges

Springer

£49.80 18 May 2026
Drug Discovery in Pancreatic Cancer: Models and Techniques
74% match

Drug Discovery in Pancreatic Cancer: Models and Techniques

Springer

£107.98 31 May 2026
Viruses and Human Cancer
74% match

Viruses and Human Cancer

Springer

£84.59 03 Jul 2026